Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04807608 · ClinicalTrials.gov registry record
EmbracePlus, Care App and Aura Usability Study
A clinical trial, sponsored by Empatica.
- Completed
- Registry status
- 335
- Enrollment target
NCT04807608: Completed study, sponsored by Empatica.
NCT04807608 is a clinical trial that has completed, run by Empatica. The registered enrollment target is 335 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04807608 has completed, sponsored by Empatica.
- COMPLETED
- Registry status
- 335 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the usability of the system which includes the wearable device, app and cloud data processing, including an algorithm (Aura) capable of detecting possible early signs of respiratory infections in healthy individuals. In addition, the investigators would like to evaluate the presence of any allergic reactions to materials used in the manufacture of the EmbracePlus.
Primary Outcome
Determine the ease of use of the system composed of EmbracePlus, Care app and Aura algorithm and user satisfaction, by means of a survey items that include both Likert-scale items that will be analyzed quantitatively and open-ended feedback that will be summarized qualitatively.
Interventions
- OTHER Usability Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 335 participants |
| Start Date | 2021-05-31 |
| Est. Completion | 2022-05-31 |
What the finished NCT04807608 record still lists
NCT04807608 is an observational study that tracks outcomes without assigning an intervention. The registered 335 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Usability Assessment is the first listed.
NCT04807608 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04807608 about?
NCT04807608 is a clinical study titled "EmbracePlus, Care App and Aura Usability Study". The purpose of this study is to evaluate the usability of the system which includes the wearable device, app and cloud data processing, including an algorithm (Aura) capable of detecting possible early signs of respiratory infections in healthy individuals. In addition, the investigators would like...
What is the current status of trial NCT04807608?
This trial is currently completed. The enrollment target is 335 participants. The study started on 2021-05-31. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT04807608?
The interventions under investigation include: Usability Assessment (OTHER).
Who is sponsoring clinical trial NCT04807608?
This trial is sponsored by Empatica, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04134754 · 335 participants · NA
Carbon Dioxide (CO2) Chemosensitivity and SUDEP
- NCT05554406 · 335 participants · Phase 2
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
- NCT06183437 · 335 participants · Phase 4
The STOP-MED CTRCD Trial
- NCT06885177 · 335 participants · NA
TECTONIC CAD IVL IDE Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI